-
Kymab announces Merck exec Simon Sturge as new CEO
pharmafile
April 11, 2019
Kymab announces Merck exec Simon Sturge as new CEO.
-
West's Asia Pacific Footprint Grows
contractpharma
April 09, 2019
West Pharmaceutical Services, Inc. has expanded its presence in the Asia Pacific region with a new sales office in Korea.
-
Lupin’s Pune Biotech facility receives EU GMP clearance
expressbpd
March 28, 2019
The GMP certification confirms that Lupin has a robust manufacturing facility that ensures consistent and controlled production as per EU quality standards.
-
Biotech firm Spiber to develop artificial hair
biospectrumasia
March 21, 2019
Spiber will use proprietary technologies to design proteins at the genetic level and produce them through fermentation in microorganisms.
-
Merck to collaborate with GenScript to accelerate cell and gene therapy industrialization in China
worldpharmanews
March 20, 2019
Merck announced the signing of a non-binding Memorandum of Understanding with Chinese biotech company GenScript for a strategic alliance focusing on plasmid and viral vector manufacturing.
-
French biotech Cellectis picks U.S. for commercial CAR-T production
fiercepharma
March 13, 2019
Cellectis is building a 14,000-square-foot facility in Paris to produce clinical supplies...
-
Pall, Broadley-James Partner on SU Technologie
contractpharma
March 12, 2019
To integrate Pall’s SU technologies with Broadley-James' SU probe and flow sensors for applications across upstream and downstream unit ops
-
Bharat Biotech acquires Chiron Behring Vaccines
biospectrumasia
February 18, 2019
Bharat Biotech will acquire 100% equity stake in Chiron Behring Vaccines in an all cash transaction.
-
Alector kicks off biotech IPOs after US government shutdown
pharmaphorum
February 14, 2019
The 35-day US government shutdown has not just played havoc at government-run agencies – it has had a knock-on effect on the stock market because of cutbacks at the Securities and Exchange Commission financial regulator.
-
UK biotech funding increased by 85 percent in 2018
europeanpharmaceuticalreview
January 29, 2019
UK-based biotech companies raised £2.2billion from investors in 2018, an increase of 85 percent from the year before, a report has found…